Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.426 | Effect of a Novel Herbal Patch for the Treatment of Plantar Fasciitis – A Single-blind Randomized Controlled Trial |
Prof. LUI Pauline Po Yee 呂寶儀 |
| 2025.214 | Investigating the Prevalence of Tendinopathy and Tendon Injuries in Patients with Metabolic Syndrome: The Impact of Metabolic Drugs | Prof. LUI Pauline Po Yee |
| 2025.363 | Epidemiological analytics in the realm of big data for the enhancement of the understanding of orthopaedic conditions | Prof. LUI Pauline Po Yee |
| 2025.882 | Application of exosomes-derived from tendon-derived stem cells loaded in gelatin methacrylate as an injectable biomaterial therapy for treating patients with Achilles tendinopathy: a first-in-human clinical trial | Prof. Lui Pauline Po Yee |
| 2024.105 | Development of a Biobank for Studying the Pathogenesis and Treatment of Musculoskeletal Disorders |
Prof. LUI Pauline Po Yee 呂寶儀 |
| 2024.130 | Effect of Pulsed Electromagnetic Fields on Promoting Hamstring Muscle Strength after Anterior Cruciate Ligament Reconstruction with Hamstring Autograft: A Double-Blind, Placebo-Controlled, Randomised Clinical Trial | Prof. LUI Pauline Po Yee |
| 2024.012 | Comparison of Functioning Among Dementia Patients with and without Getting Lost | Miss LUI Pui Yin |
| 2019.507 | Helicobacter pylori, Atrophic Gastritis and Intestinal Metaplasia Registry | Dr. LUI Rashid |
| 2020.588 | Guangzhou-Oxford-Taipei-HongKong International Collaborative Sessile Serrated Lesion Study | Dr. LUI Rashid |
| 2022.033 | Clinico-genomic predictors of outcomes among patients with HIV and cancer | Dr. LUI Rashid |
| 2021.217 | coMpliAnce with evideNce-based cliniCal guidelines in the managemenT of acute biliaRy pancreAtitis (MANCTRA-1). | Dr. LUI Rashid |
| 2021.145 | Multicenter prospective study of colorectal serrated lesions in the Asia-Pacific region | Dr. LUI Rashid |
| 2025.696 | Hereditary and familial cancers including early-onset neoplasms registry | Dr. LUI Rashid N. |
| 2019.304 | Single Arm, Open-label Trial on the Efficacy of Pantoprazole, Amoxicillin and Clarithromycin Triple Therapy for 14 Days as First-line Therapy for Helicobacter pylori in Hong Kong and Outcomes of Targeted Screening for Household Members |
Dr. LUI Rashid N. 雷諾信 |
| 2023.490 | International Liver cAncer Database (ILIAD) Consortium Study | Dr. LUI Rashid N.S. |
| 2023.465 | Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial | Dr. LUI Rashid N.S. |
| 2022.371 | Multicentre assessment of liver frailty using the Liver frailty index in patients with unresectable hepatocellular carcinoma (HCC) undergoing transarterial chemoembolisation (TACE) or systemic therapy | Dr. LUI Rashid N.S. |
| 2025.878 | Cross Sectional Study on the Prevalence of Pituitary Adenomas in Lynch Syndrome | Dr. Lui Rashid N.S. |
| 2025.301 | Multicentre retrospective comparative study of early-onset colorectal cancer (EOCRC): Analysis of clinicopathological, familial and prognostic differences according to the geographical location | Dr. LUI Rashid N.S. |
| 2025.312 | The impact of contemporary neoadjuvant and adjuvant chemotherapy treatment regimens on recurrence and survival in resectable, borderline resectable, locally advanced and metastatic adenocarcinoma arising from IPMN and internal validation of 2023 KYOTO Guidelines: ADENO-IPMN 2 study | Dr. LUI Rashid N.S. |
| 2021.033 | Randomized Controlled Trial of Aspirin for the Prevention of Recurrence in Liver Cancer |
Dr. LUI Rashid Nok Shun 雷諾信 |
| 2022.323 | Effectiveness of the Current Use of Hospital Authority (HA) Mobile Application HA Go in Exercise Program for Knee Osteoarthritis (OA) in Local Elderly Patients |
Ms. LUI Sweetie R. 雷蕢珊 |
| 2009.282 | Socio-demographic Risk Factors for adolescent Sports Injury in Hong Kong: A Pilot Study | Ms. Lui Tai Wah |
| 2025.139 | Epidemiology of fusariosis in NTEC | Dr. LUI Tin Long |
| 2011.282 | EFFECTIVENESS OF TOE SPREADER & DYNAMIC HALLUX VALGUS STRAP ON FOOT FUNCTION FOR JUVENILE HALLUX VALGUS - PROSPECTIVE, CROSSOVER RANDOMIZED CONTROL TRIAL | Dr. Lui Tun Hing |
| 2009.369 | Determinants and barriers for help seeking in persons with self-harm and aggressive ideations | Dr. Lui Victor Wing Cheong |
| 2010.081 | Oncogenic Regulation of TIGAR by STAT3: A Mechanistic Study | Ph.D. LUI Vivian Wai Yan |
| 2017.145 | RAC1 Genomic Alterations Drive Head and Neck Cancer Progression |
Dr. LUI Vivian Wai Yan 呂偉欣 |
| 2017.293 | ALK/PIK3CA Genetic Coupling: Implications for Progression and Personalized Therapy in Head and Neck Cancer |
Dr. LUI Vivian Wai Yan 呂偉欣 |
| 2011.612 | Comparison of satisfaction with communication during general outpatient consultation of doctors and patients | Ms Lui Wai Yan |
| 2008.195 | High-Content Screening (HCS) Platform for Molecular Drug Testing, Therapeutic Target Identification and Mechanistic Signaling Studies in Asian Prevalent Cancers | Ph.D., Assistant Professor LUI Wai Yan Vivian |
| 2008.196 | Biological Implication of Elefated Serum Hepatocyte Growth Factor (HGF) in the Progressionof Nasopharyngeal Carcinoma (NPC) | Ph.D., Assistant Professor LUI Wai Yan Vivian |
| 2008.022 | Oncogenic Dependency on Receptor Tyrosine Kinase (RTK): Implication for Molecular Targeting in Nasopharyngeal Carcinoma (NPC) | Ph.D., Assistant Professor LUI Wai Yan Vivian |
| 2008.365 | Validation Study of Assessment of Capacity for Everday Decision-Making for Chinese Elderly | Dr Lui Wing Cheong |
| 2014.016 | Surgical Outcome of Medial Rectus Resection for Recurrent Exotropia | Dr. LUK Abbie |
| 2015.487 | Retinopathy of Prematurity: Applicability and Compliance of Screening Guidelines in Hong Kong | Dr. LUK Abbie Sheung Wan |
| 2014.441 | A MULTICENTRE RANDOMIZED PROGRAM BY USING A DIABETIC KIDNEY DISEASE (DKD) REGISTRY TO TREAT TO MULTIPLE TARGETS (TMT) (DKD-TMT) | Dr. LUK Andrea |
| 2014.426 | A STUDY TO EVALUATE THE EFFECT OF BTI320 (SUGARDOWN®) ON POST-PRANDIAL HYPERGLYCAEMIA IN HIGH RISK CHINESE SUBJECTS WITH PRE-DIABETES | Dr. LUK Andrea On Yan |
| 2017.298 | Incidence of diabetes and diabetes-related complications in Hong Kong | Dr. LUK Andrea On Yan |
| 2017.436 | Single - Dose, Randomized, Open-Label, Two-Way Crossover Study to Evaluate the Bioequivalence of Azilsartan Tablets in Chinese Healthy Volunteers |
Dr. LUK Andrea On Yan 陸安欣 |
| 2016.046 | Interactive effects of testosterone, estradiol and CAG repeat polymorphism of androgen receptor gene on cardiovascular-renal diseases and mortality in men with type 2 diabetes |
Dr. LUK Andrea On Yan 陸安欣 |
| 2014.056 | A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 26-WEEK MULTICENTER STUDY WITH A 78-WEEK EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF ERTUGLIFLOZIN IN SUBJECTS WITH TYPE 2 DIABETES MELLITUS AND INADEQUATE GLYCEMIC CONTROL ON METFORMIN MONOTHERAPY | Dr. LUK Andrea On Yan |
| 2017.167 | Single-center, randomized, double-blind, placebo-controlled, single-dose and multiple-dose, parallel-group study to investigate pharmacokinetics, pharmacodynamics, safety and tolerability of vericiguat in Chinese healthy male subjects under fed condition |
Dr. LUK Andrea On Yan 陸安欣 |
| 2017.248 | A different level of single-dose and multiple-dose study to evaluate the pharmacokinetics of ranolazine in a Chinese population |
Dr. LUK Andrea On Yan 陸安欣 |
| 2017.451 | A RANDOMIZED, SPONSOR-OPEN, INVESTIGATOR-BLINDED, SUBJECT-BLINDED, PLACEBO-CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF RO7020531 AND METABOLITES FOLLOWING ORAL ADMINISTRATION TO CHINESE HEALTHY VOLUNTEERS |
Dr. LUK Andrea On Yan 陸安欣 |
| 2015.208 | Using C-peptide, anti-glutamic acid decarboxylase antibodies and body mass index to identify patients with young-onset type 2 diabetes for early insulin therapy | Dr. LUK Andrea On Yan |
| 2014.699 | Dose-response study of gevokizumab (S 78989 3mg, 10mg, 30mg or 60mg in patients with type 2 diabetes and diabetic kidney disease (DKD). A 66-week, international, multicenter, randomized, double-blind, parallel-group, placebo controlled, study. | Dr. LUK Andrea On Yan |
| 2016.264 | Single center, randomized, open labeled pharmacokinetics study of Azilsartan Tablets in Chinese healthy volunteers | Dr. LUK Andrea On Yan |
| 2015.540 | A randomized, double-blind, placebo-controlled, parallel-group, multicenter, event-driven Phase III study to investigate the efficacy and safety of finerenone, in addition to standard of care, on the progression of kidney disease in subjects with type 2 diabetes mellitus and the clinical diagnosis of diabetic kidney disease |
Prof. LUK Andrea On Yan 陸安欣 |
| 2016.261 | Establishment of a registry on young-onset diabetes in Asia |
Dr. LUK Andrea On Yan 陸安欣 |
Page 174 of 289.

